ArticleMolecular medicine reports2021

Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells.

Jie Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.